Skip to main content
Back
Activeted-395976-2026

Electronic Anesthesia Record System for University Hospital

Procurement, installation, and commissioning of an electronic anesthesia record system, including a sluice and recovery room module, integrated with HIS and medical equipment.

View original source

CONTRACTING AUTHORITY

Name

UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE

City

Szczecin

Country

PL

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

48180000, Medical software package.

Other CPV

48000000, Software package and information systems.

ADDITIONAL DETAILS

EU Funded

Yes

Suitable for SMEs

Yes

Electronic Submission

Required

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

14 days remaining

(LOT-0001)

Published

TENDER DOCUMENTS

14 days remaining

Similar Tenders

Explore CPV 48
PLN 61,056

Delivery of medicinal products for programs and chemotherapy at USK-2 PUM in Szczecin

We are seeking suppliers for medicinal products used in treatment programs and for cancer chemotherapy for the clinics of USK-2 PUM in Szczecin. The delivery includes a wide range of pharmaceuticals compliant with legal regulations.

UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE

·Szczecin
Deadline:July 09, 2026
PLN 33,311

Supply of Pharmaceuticals for Cancer Therapy and Special Treatment Programs for Clinics in Szczecin

Seeking a reliable supplier for pharmaceuticals used in special treatment programs and cancer chemotherapy at the USK-2 PUM clinics in Szczecin. The supply includes prescription drugs and medical devices.

UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE

·Szczecin
Deadline:July 06, 2026

Hysteroscope Instruments for Obstetrics and Gynecology Clinic

Procurement of hysteroscope instruments for the University Hospital in Szczecin. Delivery must be within 30 days, with instruments being new and having a minimum 24-month warranty.

UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE

·Szczecin
Deadline:July 06, 2026
PLN 6.5M

Active Ingredient Mirvetuximabum Soravtansinum for Ovarian Cancer Therapy

Seeking the supply of the active ingredient Mirvetuximabum Soravtansinum for the medication program B.50 to treat ovarian cancer. Delivery will be to the University Hospital in Szczecin.

UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE

·Szczecin
Deadline:June 12, 2026

Find matching tenders automatically

With Patterno-HIT, receive relevant tenders daily, automatically filtered to your company profile.

Book Demo Now